These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7138750)

  • 41. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism.
    Peacock M; Bilezikian JP; Klassen PS; Guo MD; Turner SA; Shoback D
    J Clin Endocrinol Metab; 2005 Jan; 90(1):135-41. PubMed ID: 15522938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism.
    Silverberg SJ; Bone HG; Marriott TB; Locker FG; Thys-Jacobs S; Dziem G; Kaatz S; Sanguinetti EL; Bilezikian JP
    N Engl J Med; 1997 Nov; 337(21):1506-10. PubMed ID: 9366582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppression by calcium of serum levels of intact parathyroid hormone in patients with primary hyperparathyroidism.
    Bergenfelz A; Valdermarsson S; Ahrén B
    Horm Res; 1993; 39(3-4):146-51. PubMed ID: 8262476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment with active vitamin D (alphacalcidol) in patients with mild primary hyperparathyroidism.
    Lind L; Wengle B; Sørensen OH; Wide L; Akerström G; Ljunghall S
    Acta Endocrinol (Copenh); 1989 Feb; 120(2):250-6. PubMed ID: 2644746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicenter clinical trial of 22-oxa-1,25-dihydroxyvitamin D3 for chronic dialysis patients.
    Yasuda M; Akiba T; Nihei H
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S108-11. PubMed ID: 12612965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disturbance of basal and stimulated serum levels of intact parathyroid hormone in primary hyperparathyroidism.
    Ljunghall S; Larsson K; Lindh E; Lindqvist U; Rastad J; Akerström G; Wide L
    Surgery; 1991 Jul; 110(1):47-53. PubMed ID: 1907770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of the oral calcium-loading test with measurement of intact parathyroid hormone in the diagnosis of symptomatic subtle primary hyperparathyroidism.
    Monchik JM; Lamberton RP; Roth U
    Surgery; 1992 Dec; 112(6):1103-9; discussion 1109-10. PubMed ID: 1455312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absence of effect of 24,25-dihydroxyvitamin D3 in primary hyperparathyroidism.
    Netelenbos JC; Asscheman H; Lips P; Van der Vijgh WJ; Jongen MJ; Van Ginkel F; Hackeng WH
    J Clin Endocrinol Metab; 1986 Jul; 63(1):246-8. PubMed ID: 3486877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Successful gastric ulcer treatment of a patient with primary hyperparathyroidism with cimetidine (author's transl)].
    Simon B; Stiehl A; Feurle G; Kommerell B
    Med Klin; 1978 Oct; 73(43):1513-6. PubMed ID: 713956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of cimetidine on serum carboxyl and aminoterminal fragments of parathyroid hormone in chronic uraemic patients.
    Dupont P; Carlier B; Marchetti M; Ducobu J; Van der Donckt C
    Acta Endocrinol (Copenh); 1984 Jan; 105(1):66-71. PubMed ID: 6695546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment.
    Adami S; Mian M; Bertoldo F; Rossini M; Jayawerra P; O'Riordan JL; Lo Cascio V
    Clin Endocrinol (Oxf); 1990 Sep; 33(3):391-7. PubMed ID: 2147599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decrease of serum calcium concentration and lost influence of calcium on parathyroid hormone release in a patient with primary hyperparathyroidism after treatment with diphosphonates.
    Kotzmann H; Bernecker P; Svoboda T; Niederle B; Luger A
    Calcif Tissue Int; 1993 Nov; 53(5):301-3. PubMed ID: 8287315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cimetidine in primary hyperparathyroidism.
    Ljunghall S; Akerström G; Rudberg C; Wide L; Johansson H
    Lancet; 1980 Aug; 2(8192):480. PubMed ID: 6106124
    [No Abstract]   [Full Text] [Related]  

  • 54. Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients.
    Fukagawa M; Yumita S; Akizawa T; Uchida E; Tsukamoto Y; Iwasaki M; Koshikawa S;
    Nephrol Dial Transplant; 2008 Jan; 23(1):328-35. PubMed ID: 17717030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
    Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stimulation and suppression of intact parathyroid hormone (PTH1-84) in normal subjects and hyperparathyroid patients.
    Lips P; Netelenbos JC; van Doorn L; Hackeng WH; Lips CJ
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):35-40. PubMed ID: 1909609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism.
    Ramirez JA; Goodman WG; Gornbein J; Menezes C; Moulton L; Segre GV; Salusky IB
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1489-94. PubMed ID: 8501155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
    Lindberg JS; Moe SM; Goodman WG; Coburn JW; Sprague SM; Liu W; Blaisdell PW; Brenner RM; Turner SA; Martin KJ
    Kidney Int; 2003 Jan; 63(1):248-54. PubMed ID: 12472790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Demonstration of a diurnal variation in serum parathyroid hormone in primary and secondary hyperparathyroidism.
    Sinha TK; Miller S; Feming J; Khairi R; Edmondson J; Johnston CC; Bell NH
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1009-13. PubMed ID: 1239461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.